These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 4391239)
1. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report. Devadason C Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239 [No Abstract] [Full Text] [Related]
2. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368 [No Abstract] [Full Text] [Related]
4. Double-blind controlled clinical trial of clofazimine in reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Br Med J; 1970 Jan; 1(5690):198-200. PubMed ID: 4904935 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of Lamprene (Geigy). A preliminary report. Karuru ER Lepr Rev; 1970 Apr; 41(2):83-8. PubMed ID: 5453083 [No Abstract] [Full Text] [Related]
6. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)). Morgan J Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679 [No Abstract] [Full Text] [Related]
7. Treatment of leprosy with Lampren (B.663 Geigy). De las Aguas JT Int J Lepr Other Mycobact Dis; 1971; 39(2):493-503. PubMed ID: 4948089 [No Abstract] [Full Text] [Related]
8. Effect of B.1912, a new riminophenazine derivative in murine leprosy. Chang YT Int J Lepr Other Mycobact Dis; 1970; 38(4):417-21. PubMed ID: 5534494 [No Abstract] [Full Text] [Related]
9. A study of skin pigmentation by clofazimine. Levy L; Randall HP Int J Lepr Other Mycobact Dis; 1970; 38(4):404-16. PubMed ID: 5534493 [No Abstract] [Full Text] [Related]
11. The use of B 663 (clofazimine) in the treatment of Chinese leprosy patients with chronic reaction. Warren AG Lepr Rev; 1970 Apr; 41(2):74-82. PubMed ID: 5453082 [No Abstract] [Full Text] [Related]
12. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report. Tolentino JG; Rodriquez JN; Abalos RM Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924 [No Abstract] [Full Text] [Related]
13. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)). Schulz EJ Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819 [No Abstract] [Full Text] [Related]
14. Evaluation of B.663 in human leprosy. Atkinson AJ; Sheagren JN; Rubio JB; Knight V Int J Lepr Other Mycobact Dis; 1967; 35(2):119-27. PubMed ID: 5338956 [No Abstract] [Full Text] [Related]
15. G 30 320 or B 663--lampren (Geigy). Waters MF Lepr Rev; 1969 Jan; 40(1):21-47. PubMed ID: 4888382 [No Abstract] [Full Text] [Related]
16. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472 [No Abstract] [Full Text] [Related]
17. Treatment of leprosy with a phenazine derivative (B 663 or G 30 320)--clofazimine. Gatti JC; Cardama JE; Balina LM; Crespi HG; Bianchi O; Santabaya E; Farina MH Lepr Rev; 1970 Apr; 41(2):89-92. PubMed ID: 5453084 [No Abstract] [Full Text] [Related]
18. Histochemistry of B663 pigmentation: ceroid-like pigmentation in macrophages. Sakurai I; Skinsnes OK Int J Lepr Other Mycobact Dis; 1977; 45(4):343-54. PubMed ID: 75860 [TBL] [Abstract][Full Text] [Related]
19. Clofazimine in leprosy. Schulz EJ Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339 [No Abstract] [Full Text] [Related]
20. Lipids in leprosy. 2. Histochemistry of lipids in human leprosy. Sakurai I; Skinsnes OK Int J Lepr Other Mycobact Dis; 1970; 38(4):389-403. PubMed ID: 4102020 [No Abstract] [Full Text] [Related] [Next] [New Search]